相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。delta-Secretase-cleaved Tau stimulates A beta production via upregulating STAT1-BACE1 signaling in Alzheimer's disease
Zhentao Zhang et al.
MOLECULAR PSYCHIATRY (2021)
Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes
Nazanin Rohani et al.
CANCER RESEARCH (2019)
Acidosis and proteolysis in the tumor microenvironment
Kyungmin Ji et al.
CANCER AND METASTASIS REVIEWS (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies
Jie Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Plant Vacuolar Processing Enzymes
Barend Juan Vorster et al.
FRONTIERS IN PLANT SCIENCE (2019)
Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology
Stephen D. Ginsberg et al.
NEUROBIOLOGY OF DISEASE (2019)
Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease
Zhi-Hao Wang et al.
CELL REPORTS (2019)
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease
Antoine Leuzy et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer's disease: A systematic literature review
Leonie C. P. Banning et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
α-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease
Seong Su Kang et al.
EMBO JOURNAL (2018)
Mechanism of Tau Hyperphosphorylation Involving Lysosomal Enzyme Asparagine Endopeptidase in a Mouse Model of Brain Ischemia
Gustavo Basurto-Islas et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury
Wen Hu et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states
Elfriede Dall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
Victor L. Villemagne et al.
NATURE REVIEWS NEUROLOGY (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease
Lawrence S. Honig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer's disease
Chun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease
Zhi-Hao Wang et al.
NATURE COMMUNICATIONS (2018)
Selective vulnerability in neurodegenerative diseases
Hongjun Fu et al.
NATURE NEUROSCIENCE (2018)
Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies
Zhi-Hao Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease
Hualong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression
Hsu-Hsin Chen et al.
SCIENTIFIC REPORTS (2018)
Molecular basis for the production of cyclic peptides by plant asparaginyl endopeptidases
M. A. Jackson et al.
NATURE COMMUNICATIONS (2018)
BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT
Zhi-Hao Wang et al.
JCI INSIGHT (2018)
Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells
Hanna Wallin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease
Zhi-Hao Wang et al.
MOLECULAR CELL (2017)
Not just amyloid: physiological functions of the amyloid precursor protein family
Ulrike C. Mueller et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Animal models of α-synucleinopathy for Parkinson disease drug development
James B. Koprich et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
Zhentao Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2017)
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
Zhentao Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions
Ngoc Nguyen Lunde et al.
BIOCHIMIE (2017)
Structure and function of legumain in health and disease
Elfriede Dall et al.
BIOCHIMIE (2016)
Calpastatin inhibits motor neuron death and increases survival of hSOD1G93A mice
Mala V. Rao et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Mammalian prions and their wider relevance in neurodegenerative diseases
John Collinge
NATURE (2016)
Caspase-2 cleavage of tau reversibly impairs memory
Xiaohui Zhao et al.
NATURE MEDICINE (2016)
Structure and Mechanism of an Aspartimide-Dependent Peptide Ligase in Human Legumain
Elfriede Dall et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Expression and protease activity of mouse legumain are regulated by the oncogene/transcription co-activator, DJ-1 through p53 and cleavage of annexin A2 is increased in DJ-1-knockout cells
Takuya Yamane et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Development of a potent and selective cell penetrant Legumain inhibitor
Kerry A. Ness et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Michael Willem et al.
NATURE (2015)
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2015)
Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain
Andre Jeronimo-Santos et al.
CEREBRAL CORTEX (2015)
Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage
Lixia Zhao et al.
CELL RESEARCH (2014)
Functional Role of Asparaginyl Endopeptidase Ubiquitination by TRAF6 in Tumor Invasion and Metastasis
Yingying Lin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Zhentao Zhang et al.
NATURE MEDICINE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Transcriptional regulation of the legumain gene by p53 in HCT116 cells
Takuya Yamane et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Autoactivation of prolegumain is accelerated by glycosaminoglycans
Lise Berven et al.
BIOCHIMIE (2013)
How it all Started: Tau and Protein Phosphatase 2A
Chang Liu et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease
Gustavo Basurto-Islas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation
Elfriede Dall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile
Elfriede Dall et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2012)
An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide
Silvia Bolognin et al.
ACTA NEUROPATHOLOGICA (2012)
SRPK2 Phosphorylates Tau and Mediates the Cognitive Defects in Alzheimer's Disease
Yi Hong et al.
JOURNAL OF NEUROSCIENCE (2012)
Asparaginyl endopeptidase cleaves TDP-43 in brain
Jeremy H. Herskowitz et al.
PROTEOMICS (2012)
A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology
Takenari Yamashita et al.
NATURE COMMUNICATIONS (2012)
Asparagine endopeptidase is required for normal kidney physiology and homeostasis
Gail Miller et al.
FASEB JOURNAL (2011)
Nucleoplasmic calcium regulates cell proliferation through legumain
Viviane Andrade et al.
JOURNAL OF HEPATOLOGY (2011)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Blastocystis Legumain Is Localized on the Cell Surface, and Specific Inhibition of Its Activity Implicates a Pro-survival Role for the Enzyme
Binhui Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Distinct Protease Requirements for Antigen Presentation In Vitro and In Vivo
Stephen P. Matthews et al.
JOURNAL OF IMMUNOLOGY (2010)
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Ian R. A. Mackenzie et al.
LANCET NEUROLOGY (2010)
Caspase activation precedes and leads to tangles
Alix de Calignon et al.
NATURE (2010)
Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome
Chi-Bun Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Yong-Jie Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CCAAT/enhancer binding protein β deficiency provides cerebral protection following excitotoxic injury
Marta Cortes-Canteli et al.
JOURNAL OF CELL SCIENCE (2008)
Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase
Zhixue Liu et al.
MOLECULAR CELL (2008)
Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells
Yoshikata Morita et al.
FEBS LETTERS (2007)
The generation of a 17 kDa neurotoxic fragment:: An alternative mechanism by which tau mediates β-amyloid-induced neurodegeneration
SY Park et al.
JOURNAL OF NEUROSCIENCE (2005)
Proteolysis of non-phosphorylated and phosphorylated tau by thrombin
T Arai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Microarray analysis supports a role for CCAAT/enhancer-binding protein-β in brain injury
M Cortés-Canteli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A plant vacuolar protease, VPE, mediates virus-induced hypersensitive cell death
N Hatsugai et al.
SCIENCE (2004)
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
RA Rissman et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo
DTN Ni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone
B Manoury et al.
IMMUNITY (2003)
Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones
AJ Niestroj et al.
BIOLOGICAL CHEMISTRY (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment
SJ Choi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
分享论文
